EOM Pharmaceuticals

#EOM today announced its name change from ImmunoCellular Therapeutics Ltd., to EOM Pharmaceutical Holdings, Inc. The name change follows from the merger between EOM Pharmaceuticals, Inc. and ImmunoCellular Therapeutics Ltd. on December 1, 2021. Read here: bit.ly/3UN8CtN

#TeamEOM thanks all healthcare providers around the world this #NationalDoctorsDay! We respect your dedication to your patients and the health of your community. Take the opportunity today to thank the #healthcare providers in your life!

Shalom Z. Hirschman, M.D., the Co-Founder, Chief Scientific Officer & Medical Director at #EOMpharma explains the company’s pipeline. Learn more about him here: bit.ly/2Mdn93N #TeamEOM #relentlessscience

March is #NationalNutritionMonth and a great opportunity to raise awareness for developing heathy eating & physical activity habits. It is also important to highlight the role that nutrition plays in patients dealing with cancer cachexia. Learn more here: bit.ly/3vNejyk

#DYK that rare diseases currently affect 5% of the worldwide population? Find out more information about #RareDiseaseDay and how to get involved here: bit.ly/35ByLY1

February is #NationalCancerPreventionMonth and an important opportunity to read about the different preventable causes of cancer and the actions you can take to reduce your risk of certain cancers. You can learn more about cancer prevention here: bit.ly/3ujXpaa

Wayne I. Danson, CPA, the Chief Financial Officer & Treasurer at #EOMpharma on what drives #TeamEOM. Get to know Wayne here: bit.ly/2Mdn93N #entrepreneur #relentlessscience

#DYK February is National Age-related Macular Degeneration (AMD) and Low Vision Awareness Month? Vision impairment affects millions of Americans, but vision rehabilitation and other services are available. Find out more information about AMD here: bit.ly/3IXv6lS

In honor of #WorldCancerDay, #EOMpharma encourages everyone to learn about the global initiative focusing on raising awareness of the prevention, detection, and treatment of cancer, including cancer cachexia, to help #ClosetheCareGap. Learn more here: bit.ly/3L2xolv

We are honored to receive a Digital Health Merit Award from @DHealthAwards for our investigational EOM613 MOA video. Cheers to compelling #science and thanks to our creative agency #TogoRun for bringing it to life. Watch the full video here: bit.ly/3IrLA68 #Fall21DHA

#EOM & @ImmunoCellular announce definitive merger agreement forming EOM Pharmaceuticals Holdings, Inc. Focus: advancing novel immunomodulatory & retinal investigational agents, EOM613 in trials as potential #COVID19 treatment in #Brazil. More here: bit.ly/3luZv1w

#EOMpharma announces first patients dosed in R1: RESCUE, a Phase 1/2a open-label trial evaluating lead asset EOM613 in treatment of hospitalized #COVID19 patients in #Brazil. You can read more about the study here: bit.ly/38o9DCt

Congrats to #TeamEOM’s Scientific Advisor, Dr. Frank L. Douglas, on his important article in @PharmExec regarding how big pharma can improve #Diversity and #Inclusion in their companies and drug development. You can read the full article here: bit.ly/3AwZFdQ #equality

#EOMpharma announces addition to team with Frank L. Douglas, Ph.D., M.D., as Scientific Advisor! You can learn more about this award-winning industry veteran here: bit.ly/2UD94kO #TeamEOM #entrepreneur

#DYK: The prevalence of #cachexia is as high as 87% in people with pancreatic and gastric #cancer. Learn more about the different cancers most commonly affected by cachexia here: bit.ly/3cb8ssO #relentlessscience

Today is National Asian & Pacific Islander HIV/AIDS Awareness Day and we are joining others to increase awareness and end silence and shame surrounding #HIV in these communities. Learn more here: bit.ly/3cwijcw #APIMay19 #NAPIHAAD

#EOMpharma wishes a happy #MothersDay to all of the important mother figures in our lives and encourages all women to make their health a priority by going in for regular check-ups!

#DYK: #Cachexia is a complex syndrome that affects more than 80% of advanced #cancer patients? You can read more about the condition here: bit.ly/3cb8ssO #relentlessscience

#DYK: #Cachexia is a wasting syndrome that contributes to more than 20% of cancer deaths? Learn more: bit.ly/3cb8ssO #relentlessscience

April is National Minority Health Month, which raises awareness about health disparities that continue to affect racial and ethnic minority communities. Find out more about the #VacccineReady theme for #NMHM2021 here: bit.ly/31ucjLb